DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Motzer RJ, Tannir NM, McDermott DF. et al.
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.
The New England journal of medicine 2018;
378: 1277-1290
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.